ONCR
Oncorus Inc

509
Loading...
Loading...
Oncorus, Inc. engages in the research and development of a viral immunotherapy platform. It develops an immunotherapy platform to treat cancer such as oncolytic Herpes Simplex Virus Platform and Synthetic Virus Platform. The company was founded by Mitchell H. Finer, Joseph C. Glorioso III, Kenneth P. Greenberg, Cyrus D. Mozayeni, and Paola Grandi on April 1, 2015 and is headquartered in Andover, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oncorus Inc?
What is the 52-week high for Oncorus Inc?
What is the 52-week low for Oncorus Inc?
What is Oncorus Inc stock price today?
What was Oncorus Inc stock price yesterday?
What is the PE ratio of Oncorus Inc?
What is the Price-to-Book ratio of Oncorus Inc?
What is the 50-day moving average of Oncorus Inc?

Latest ONCR News

View
No ONCR news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.